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Non-viral synthetic gene therapy reagents offer excellent structural and chemical versatility 
within non-immunogenic delivery systems, coupled with high therapeutic gene carrying capacity 
and long shelf life, making them attractive alternatives to viral systems. The success of non-viral 
transfection using polymers hinges on efficient nuclear uptake of nucleic acid cargo and 
overcoming intra- and extracellular barriers.  This poster will describe the integration of the 
PKKKRKV heptapeptide (the Simian virus SV40 large T-antigen nuclear localization sequence, 
NLS) onto a polymer backbone, and the resultant high reporter gene expression in mice when 
administered by intramuscular ultrasound-mediated delivery. These novel polymers afforded 
protein expression higher than JetPEI™ in vivo, and in cell culture outperformed commercial 
reagents JetPEI™ and Lipofectamine 2000™, the latter being notorious for coupling high 
transfection efficiency with cytotoxicity. The orientation of the NLS peptide grafts relative to the 
polymer backbone markedly affected transfection performance both in vitro and in vivo. 
Quantitative polymerase chain reaction (qPCR) studies on transfected cells showed that 
polymers having the NLS attached at the valine residue afforded higher nuclear translocation, 
and subsequently higher protein expression, relative to those having the NLS groups attached 
in the opposite orientation. Besides nuclear uptake, the superior binding characteristics of these 
comb polymers compared to linear polylysine, as judged by atomistic and coarse grain 
simulations as well as polymer-DNA binding experiments, contributes to their enhanced 
transfection performance. Polyplexes formed from these comb polymer structures exhibit low 
cytotoxicity and high transfection efficiency both in vitro and in vivo, demonstrating the 
therapeutic promise of these novel gene therapy reagents. 
  
 
